GSK vet Antony Blanc signs on to be­come Cure­Vac's CBO and CCO; Chris Ca­bell out, Paul Streck in as Are­na Phar­ma­ceu­ti­cals CMO

→ En­thused about the Phase I da­ta for their Covid-19 mR­NA vac­cine and be­liev­ing they’ve cracked the cold-stor­age code in de­liv­er­ing them, Cure­Vac has brought Antony Blanc in­to the fray as CBO and chief com­mer­cial of­fi­cer. While at GSK from 2009-17, Blanc served in sev­er­al ca­pac­i­ties with GSK Vac­cines, in­clud­ing as in­te­gra­tion lead when the phar­ma gi­ant ac­quired No­var­tis Vac­cines in 2015. Be­fore his time at GSK, Blanc was CBO at Syn­osia Ther­a­peu­tics.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.